Demoxytocin
From Wikipedia, the free encyclopedia
| Demoxytocin | |
|---|---|
 |
|
|
2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-N-(carbamoylmethyl)-4-methylpentanamide |
|
| Identifiers | |
| CAS number | 113-78-0 |
| PubChem | 8229 |
| KEGG | D07228  |
| MeSH | deaminooxytocin |
| Jmol-3D images | Image 1 |
|
|
| Properties | |
| Molecular formula | C43H65N11O12S2 |
| Molar mass | 992.17 g mol−1 |
 (verify) (what is:  / ?)Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references |
Demoxytocin (INN, trade name Sandopart) or deaminooxytocin, is an obstetric drug often used in the prevention of puerperal mastitis. It is an analogue of oxytocin.
[edit] See also
[edit] References
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (August 2009) |
|
|
|
 |
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
